CRISPR Therapeutics (CRSP) PT Lowered to $139 at Stifel

July 30, 2021 8:53 AM EDT Send to a Friend

Stifel analyst Benjamin J. Burnett ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

CRISPR Therapeutics (CRSP) PT Lowered to $139 at Stifel

Member Login

Free News Feed